Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Keenan Research Centre for Biomedical Science, St Michael's Hospital, Toronto, ON, Canada.
Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada.
Br J Anaesth. 2024 Aug;133(2):424-436. doi: 10.1016/j.bja.2024.03.043. Epub 2024 May 29.
Postoperative pulmonary complications (PPCs) are associated with postoperative mortality and prolonged hospital stay. Although intraoperative mechanical ventilation (MV) is a risk factor for PPCs, strategies addressing weaning from MV are understudied. In this systematic review, we evaluated weaning strategies and their effects on postoperative pulmonary outcomes.
Our protocol was registered on PROSPERO (CRD42022379145). Eligible studies included randomised controlled trials and observational studies of adults weaned from MV in the operating room. Primary outcomes included atelectasis and oxygenation; secondary outcomes included lung volume changes and PPCs. Risk of bias was assessed using the Cochrane Risk of Bias (RoB2) tool, and quality of evidence with the GRADE framework.
Screening identified 14 randomised controlled trials including 1719 patients; seven studies were limited to the weaning phase and seven included interventions not restricted to the weaning phase. Strategies combining pressure support ventilation (PSV) with positive end-expiratory pressure (PEEP) and low fraction of inspired oxygen (FiO) improved atelectasis, oxygenation, and lung volumes. Low FiO improved atelectasis and oxygenation but might not improve lung volumes. A fixed-PEEP strategy led to no improvement in oxygenation or atelectasis; however, individualised PEEP with low FiO improved oxygenation and might be associated with reduced PPCs. Half of included studies are of moderate or high risk of bias; the overall quality of evidence is low.
There is limited research evaluating weaning from intraoperative MV. Based on low-quality evidence, PSV, individualised PEEP, and low FiO may be associated with reduced postoperative pulmonary outcomes.
PROSPERO (CRD42022379145).
术后肺部并发症(PPCs)与术后死亡率和住院时间延长有关。虽然术中机械通气(MV)是 PPCs 的一个危险因素,但针对 MV 脱机的策略研究较少。在这项系统评价中,我们评估了脱机策略及其对术后肺部结局的影响。
我们的方案已在 PROSPERO(CRD42022379145)上注册。符合条件的研究包括在手术室中对 MV 进行脱机的随机对照试验和观察性研究。主要结局包括肺不张和氧合;次要结局包括肺容量变化和 PPCs。使用 Cochrane 风险偏倚(RoB2)工具评估风险偏倚,并使用 GRADE 框架评估证据质量。
筛选出 14 项随机对照试验,共纳入 1719 例患者;其中 7 项研究仅限于脱机阶段,7 项研究包括不限于脱机阶段的干预措施。结合压力支持通气(PSV)与呼气末正压(PEEP)和低吸入氧分数(FiO)的策略可改善肺不张、氧合和肺容量。低 FiO 可改善肺不张和氧合,但可能不会改善肺容量。固定 PEEP 策略对氧合或肺不张无改善;然而,低 FiO 的个体化 PEEP 可改善氧合,并可能与减少 PPCs 有关。纳入的研究中有一半存在中高风险偏倚;总体证据质量较低。
评估术中 MV 脱机的研究有限。基于低质量证据,PSV、个体化 PEEP 和低 FiO 可能与减少术后肺部结局有关。
PROSPERO(CRD42022379145)。